Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin

Circulation - United States
doi 10.1161/01.cir.0000142859.77578.c9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Assessment of Pregnancy Outcome With Low Molecular Weight Heparin Therapy: A Retrospective, Single Centre Observational Study

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

P10 Risks of Low Molecular Weight Heparin in Suspected Pulmonary Embolism

Thorax
PulmonaryRespiratory Medicine
2011English

Risk of Clinical Pulmonary Embolism After Joint Surgery in Patients Receiving Low-Molecular-Weight Heparin Prophylaxis in Hospital

Acta Orthopaedica Scandinavica
2003English

Low Molecular-Weight Heparin Is Better Than Warfarin for Prevention of Recurrent Venous Thromboembolism in Cancer Patients

Clinical Research in Practice: The Journal of Team Hippocrates
2017English

Low Molecular Weight Heparin

Reactions Weekly
2014English

Low Molecular Weight Heparin

Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular MedicineAnesthesiologyPain MedicineCardiology
1992English

Low Molecular Weight Heparin

Reactions Weekly
2013English

Low Molecular Weight Heparin

2020English

Strength of Evidence for Low-Molecular-Weight Heparin

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy